FindTrial
Sign In

Clinical characteristics and prognosis analysis of fibrotic interstitial lung disease

Clinical characteristics and prognosis analysis of fibrotic interstitial lung disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300075818
Enrollment
Unknown
Registered
2023-09-15
Start date
2023-09-17
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fibrotic interstitial lung disease

Interventions

Case series:none

Sponsors

Beijing Chaoyang Hospital Affiliated of Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Confirmed f-ILD by a multidisciplinary team; (2) Age>18 years old; (3) All patients signed informed consent forms.

Exclusion criteria

Exclusion criteria: (1) HRCT fibrosis accumulation range<10%; (2) patients with severe heart, liver, and kidney dysfunction; (3) Patients who withdrew from the study due to personal factors during the study; (4) Tumor history; (5) Pregnant or lactating women; (6) Lost of follow-up.

Design outcomes

Primary

MeasureTime frame
Lung Function;—

Secondary

MeasureTime frame
High-Resolution CT;—

Countries

China

Contacts

Public ContactYe Qiao

Beijing Chaoyang Hospital Affiliated of Capital Medical University

yeqiao_chaoyang@sina.com+86 134 3652 0511

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026